A-One Biotech & Tissue Culture Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 13.29 Cr
as on 19-12-2024
- Satisfied Charges ₹ 1.40 Cr
as on 19-12-2024
- Revenue 23.11%
(FY 2021)
- Profit 5.26%
(FY 2021)
- Ebitda 97.81%
(FY 2021)
- Net Worth 17.49%
(FY 2021)
- Total Assets 23.68%
(FY 2021)
About A-One Biotech & Tissue Culture
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹13.29 Cr. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rohini Jadhav and Dilip Jadhav serve as directors at the Company.
- CIN/LLPIN
U01403PN2009PTC134486
- Company No.
134486
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Aug 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does A-One Biotech & Tissue Culture Private Limited offer?
A-One Biotech & Tissue Culture Private Limited offers a wide range of products and services, including Agricultural & Farm Consultants, Agro Farming Services, Indoor Plants, Philodendron Plant, Decorative Plant, Contract Farming Service, Organic Farming, Syngonium, Outdoor Plant, Rubber Plant.
Who are the key members and board of directors at A-One Biotech & Tissue Culture?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dilip Jadhav | Director | 12-Aug-2009 | Current |
Rohini Jadhav | Director | 12-Aug-2009 | Current |
Financial Performance of A-One Biotech & Tissue Culture.
A-One Biotech & Tissue Culture Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 23.11% increase. The company also saw a slight improvement in profitability, with a 5.26% increase in profit. The company's net worth Soared by an impressive increase of 17.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of A-One Biotech & Tissue Culture?
In 2021, A-One Biotech & Tissue Culture had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 06 Dec 2024 | ₹2.07 Cr | Open |
Others Creation Date: 29 Jun 2022 | ₹1.45 Cr | Open |
Karnataka Bank Ltd. Creation Date: 18 Jan 2022 | ₹3.85 Cr | Open |
How Many Employees Work at A-One Biotech & Tissue Culture?
Unlock and access historical data on people associated with A-One Biotech & Tissue Culture, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A-One Biotech & Tissue Culture, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A-One Biotech & Tissue Culture's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.